logo
No Injections Needed: How Women Over 50 Are Losing Weight With Contrave

No Injections Needed: How Women Over 50 Are Losing Weight With Contrave

Yahoo17-07-2025
If you don't like the high prices that can come with popular weight-loss drugs like Ozempic—or the needle pokes they require—we have good news. A little-known oral diet pill called Contrave is affordable and helps people painlessly reach their weight-loss goals. In fact, Woman's World reader Janet Allen lost 115 pounds with it. Keep reading to learn how this easy medicine might work for you. And don't miss Janet's inspiring Contrave weight-loss success story at the end!
How Contrave speeds weight loss
You may know that injectable drugs like Ozempic work to lower blood sugar and slow stomach emptying so you feel full longer. But Contrave—an oral tablet with the active ingredients naltrexone and bupropion—works differently. It addresses the mental side of weight gain.
Hormone specialist Gowri Rocco, MD, author of Growing Younger, says, 'Contrave targets two areas of the brain involved in hunger and cravings. This can be especially helpful for women in menopause who often experience more emotional eating.'
The drug essentially works on the brain to quiet appetite and boost your mood. Those antidepressant, anti-addiction effects appeal to many yo-yo dieters. Dr. Rocco says, 'Contrave works on the brain's reward center to reduce hunger and the urge to emotionally eat. It helps rewire the brain, making it a unique tool for addressing habits rooted in the brain, not the gut.'
Contrave is a more affordable weight loss option than Wegovy
Fans say you can't beat the results for the price. While Wegovy shots are shown to help people shed 15 percent of their weight, Contrave can help people drop nearly 12 percent, finds University of Windsor research, and it costs about 90 percent less. Many patients pay $99 a month for Contrave using the CurAccess program. Compare that to the more than $1,000 a month out-of-pocket that some people pay for Ozempic or Wegovy.
Contrave works even better when paired with walking
'Obesity is a heterogeneous disease,' says Ivy-League educated obesity expert Katherine Saunders, MD, cofounder of FlyteHealth. In other words, it is caused by many different factors and thus needs different treatments. Dr. Saunders, who has given a popular TED talk about obesity care, says what works best is a 'comprehensive, personal and multifactorial treatment plan.' That means combining medication with other health habits—a duo she describes as 'life-changing and lifesaving.'
So it's no surprise that women are seeing massive results by pairing Contrave and walking. 'I see women over 50 have success every day,' says Dr. Saunders. She witnesses patients experience what science calls 'super responder-level weight loss,' meaning they shed far more weight than doctors expect. She explains, 'Contrave and other anti-obesity medications allow women who are unable to lose weight with diet and exercise alone to treat their obesity successfully.'
How walking increases weight loss on Contrave
'Walking improves insulin sensitivity and boosts mood, which enhances the effects of any strategy aimed at reducing cravings,' explains Dr. Rocco. 'When the brain's triggers are quieted and the body is moving regularly, the results often come faster and feel more sustainable. The two together create a reset for body and mind.'
The proof: A study in The Lancet found that people taking a higher dose of Contrave and walking regularly lost weight four times faster than dieters in a control group. And in a study in Obesity, people taking Contrave and walking were more than twice as likely to shed 15 percent of their weight than those who only walked.
Contrave success story: Janet lost 115 pounds during menopause
For years, Janet Allen binged salty foods when she felt stressed, sad, angry or lonely. 'The cravings were constant,' she says. 'I never actually felt hungry—I overate so often that I was always full.' She believed this weight gain was inevitable with age. 'I felt hopeless.'
When Janet finally opened up to her nurse practitioner about her wild cravings, she got some new advice: Try a prescription pill. 'That conversation changed my life,' she says. 'Finding out there was a medical option that would help me address the reasons I was eating was a breakthrough.'
She saw results quickly
Janet's appetite quickly decreased. 'I was able to catch myself before I ran to the fridge, so I could choose an alternative activity.' That activity was walking with her daughter. Slowly, 15 minutes became 30, then 45, then an hour. They soon added in hills. 'The more we moved, the more we lost,' says Janet.
Janet dropped 10 pounds in one month using Contrave and walking. The exercise also toned her body—and that helped her avoid sagging skin. 'I pinch myself. I thought getting back into shape would be impossible. This is the most weight I've ever lost. I lost faster than when I was younger.'
Janet shed more than 100 pounds and reversed her sleep apnea. 'The medicine helped with my unique situation,' she explains, whereas her daughter dropped 90 pounds simply by walking. 'When I feel hungry now, it's such a wild feeling,' she says. 'You can reclaim your life. It's not too late!'
After Contrave, Janet is 7 sizes smaller
Despite being in menopause, Janet shed a total of 115 pounds—without the sagging skin that's so common among women who lose weight. Now at 61, she's in the best shape of her life.
'The biggest 'aha' I've had is that my eating and weight management weren't about self-control or laziness. I had to get to the root of why I had been abusing food in the first place and heal from food addiction,' she says. 'People always comment about how good I look, which is great. But the real benefit is how much I've healed on the inside and the peace this journey has led to. It was as much a mental journey as a physical one!'
Additional reporting by Allison Nemetz and Cailey Griffin
Keep scrolling for more GLP-1 health news:
How to Access GLP-1 Medications Safely and Legally After the FDA's New Rules
Experts: How to Prevent Muscle Loss on Ozempic
Lose Weight for Less With Hacks Like Microdosing Ozempic—See the Simple Click Chart
This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Oscar Health (OSCR) Q2 Earnings: What To Expect
Oscar Health (OSCR) Q2 Earnings: What To Expect

Yahoo

time26 minutes ago

  • Yahoo

Oscar Health (OSCR) Q2 Earnings: What To Expect

Health insurance company Oscar Health (NYSE:OSCR) will be reporting earnings this Wednesday morning. Here's what to expect. Oscar Health beat analysts' revenue expectations by 6.9% last quarter, reporting revenues of $3.05 billion, up 42.1% year on year. It was a stunning quarter for the company, with a solid beat of analysts' EPS estimates. Is Oscar Health a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Oscar Health's revenue to grow 33.7% year on year to $2.97 billion, slowing from the 46% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.84 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Oscar Health has missed Wall Street's revenue estimates four times over the last two years. Looking at Oscar Health's peers in the health insurance providers segment, some have already reported their Q2 results, giving us a hint as to what we can expect. CVS Health delivered year-on-year revenue growth of 8.4%, beating analysts' expectations by 5.1%, and Alignment Healthcare reported revenues up 49%, topping estimates by 5.7%. CVS Health's stock price was unchanged after the resultswhile Alignment Healthcare was up 5.7%. Read our full analysis of CVS Health's results here and Alignment Healthcare's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the health insurance providers stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.3% on average over the last month. Oscar Health is down 17% during the same time and is heading into earnings with an average analyst price target of $11.29 (compared to the current share price of $13.95). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tennessee readies for execution of man with working implanted defibrillator
Tennessee readies for execution of man with working implanted defibrillator

Yahoo

timean hour ago

  • Yahoo

Tennessee readies for execution of man with working implanted defibrillator

NASHVILLE, Tenn. (AP) — Tennessee is gearing up for an execution on Tuesday that experts say would likely mark the first time a man has been put to death with a working defibrillator in his chest. Gov. Bill Lee declined Monday to grant a reprieve, clearing the way for Byron Black's execution after a legal battle and ongoing uncertainty about whether the implantable cardioverter-defibrillator will shock his heart when the lethal drug takes effect. The nonprofit Death Penalty Information Center said it's unaware of any other cases in which a person on death row made similar claims to Black's about defibrillators or pacemakers. Black's attorneys said they haven't found a comparable case, either. Lee said the courts have "universally determined that it is lawful to carry out the jury's sentence of execution given to Mr. Black for the heinous murders of Angela Clay and her daughters Lakeisha, age 6, and Latoya, age 9." The U.S. Supreme Court on Monday rejected Black's appeals. The execution would be Tennessee's second since May, after a pause for five years, first because of COVID-19 and then because of missteps by state corrections officials. Twenty-seven men have died by court-ordered execution so far this year in the U.S., and nine other people are scheduled to be put to death in seven states during the remainder of 2025. The number of executions this year exceeds the 25 carried out last year and in 2018. It is the highest total since 2015, when 28 people were put to death. Black's condition Black, 69, is in a wheelchair, and he has dementia, brain damage, kidney failure, congestive heart failure and other conditions, his attorneys have said. The implantable cardioverter-defibrillator he has is a small, battery-powered electronic device that is surgically implanted in the chest. It serves as a pacemaker and an emergency defibrillator. Black's attorneys say in order to be sure it's off, a doctor must place a programming device over the implant site, sending it a deactivation command, with no surgery required. In mid-July, a trial court judge agreed with Black's attorneys that officials must have his device deactivated to avert the risk that it could cause unnecessary pain and prolong the execution. But the state Supreme Court intervened July 31 to overturn that decision, saying the other judge lacked the authority to order the change. The state has disputed that the lethal injection would cause Black's defibrillator to shock him. Even if shocks were triggered, Black wouldn't feel them, the state said. Black's attorneys have countered that even if the lethal drug being used, pentobarbital, renders someone unresponsive, they aren't necessarily unaware or unable to feel pain. Kelley Henry, Black's attorney, said the execution could become a 'grotesque spectacle.' The legal case also spurred a reminder that most medical professionals consider participation in executions a violation of health care ethics. Black's case Black was convicted in the 1988 shooting deaths of his girlfriend Angela Clay, 29, and her two daughters. Prosecutors said he was in a jealous rage when he shot the three at their home. At the time, Black was on work-release while serving time for shooting Clay's estranged husband. Linette Bell, whose sister and two nieces were killed, recently told WKRN-TV: 'He didn't have mercy on them, so why should we have mercy on him?' Intellectual disability claim In recent years, Black's legal team has unsuccessfully tried to get a new hearing over whether he is intellectually disabled and ineligible for the death penalty under U.S. Supreme Court precedent. His attorneys have said that if they had delayed a prior attempt to seek his intellectual disability claim, he would have been spared under a 2021 state law. Nashville District Attorney Glenn Funk contended in 2022 that Black is intellectually disabled and deserved a hearing under that 2021 law, but the judge denied it. That is because the 2021 law denies a hearing to people on death row who have already filed a similar request and a court has ruled on it 'on the merits." In Funk's attempt, he focused on input from an expert for the state in 2004 who determined back then that Black didn't meet the criteria for what was then called "mental retardation.' But she concluded that Black met the new law's criteria for a diagnosis of intellectual disability. Black also sought a determination by the courts that he is incompetent to be executed.

Guardians reliever Nic Enright, battling lymphoma, earns emotional first save
Guardians reliever Nic Enright, battling lymphoma, earns emotional first save

Yahoo

timean hour ago

  • Yahoo

Guardians reliever Nic Enright, battling lymphoma, earns emotional first save

NEW YORK (AP) — The first career save for Nic Enright was a particularly meaningful one. Enright, who was diagnosed with Hodgkin lymphoma in late 2022 and is scheduled to complete his treatments later this year, allowed an unearned run in the 10th inning Monday night to close out the Cleveland Guardians' 7-6 win over the New York Mets. 'He was almost crying on the field just now,' Guardians manager Stephen Vogt said. 'If you read his story, it's pretty inspirational.' Cleveland selected Enright in the 20th round of the 2019 amateur draft out of Virginia Tech. He received his diagnosis Dec. 22, 2022 — 15 days after the Miami Marlins took him in the Rule 5 draft. After four rounds of immunotherapy in early 2023, Enright made nine minor league rehab appearances for the Marlins before being designated for assignment and returning to the Guardians in late May. He missed most of last season due to a right shoulder strain, but went 2-1 with a 1.06 ERA in 16 appearances with Triple-A Columbus. The right-hander has one more round of cancer treatment scheduled for November. 'I made the decision when I was diagnosed in 2022 with Hodgkin lymphoma that I wasn't going to let that define my life and dictate how I was going to go about my life,' Enright said. 'It's something where, for anyone else who is going through anything similar, (it shows) I haven't just holed up in my house and felt sorry for myself this whole time.' Enright made his major league debut May 25 and has a 2.01 ERA in 19 appearances for the Guardians, whose bullpen is in flux with All-Star closer Emmanuel Clase on paid leave as part of a sports gambling investigation. Hunter Gaddis and Cade Smith pitched the eighth and ninth innings Monday before Enright entered with a two-run lead. He gave up a two-out RBI single to Brett Baty before retiring Luis Torrens on a fly out to the warning track in right. 'I definitely held my breath as I saw Nolan (Jones) kind of keep running,' Enright said. 'But I had faith. As he kind of got closer to the wall, I realized it was losing steam.' Enright was showered with beer by teammates in the locker room. 'I was so happy, oh, I was going nuts in here,' Guardians starting pitcher Slade Cecconi said with a smile. 'I was going absolutely berserk. He came in running up the stairs, smile on his face.' Enright thanked his wife, his parents and the rest of his family for their support throughout an interview at his locker. He got the ball from the final out and plans to set aside his uniform and hat as well as a lineup card. 'Really, really cool,' Enright said. 'These last couple of years, especially, I've gone through a lot of adversity and just everything that's gone on. And so for me, it's being able to reflect on those in these moments. I think that helps being able to slow the game down. Because it hasn't exactly been a red-carpet rollout for my career trajectory.' ___ AP MLB:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store